¾Á¸»ŠÊ˜·³Ç

Skip to main content

Medicine and the Future of Health

Guest editors: Dr Zaheer-Ud-Din Babar, Dr Dale Fisher and Dr Paul Wicks

Pharmaceuticals constitute on average 12-18% of the healthcare budget of OECD countries but 70-90% in developing countries. With the emergence of multi drug resistant organisms, ageing populations and increasing life expectancy, it is expected that medication utilization will increase worldwide. Advances in diagnostics will contribute to greater and more targeted use of drugs while technology could also impact opportunities for personalised approaches, biotechnology and the way we develop, use and access medicines. Ethical, financial and logistical challenges will surround the constantly evolving field of pharmaceuticals particularly with regards rapid and responsible development and also access to all who need them.

This article collection, jointly published by Journal of Pharmaceutical Policy and Practice (JoPPP) and ¾Á¸»ŠÊ˜·³Ç Medicine, is a cross-journal collaboration. It will cover recent advances in drug development, medicines use, policy and access, that has both broad interest and high clinical and public health relevance due to their impact on the future of health.

We are now seeking submissions of original research, in-depth reviews, opinions and debates offering novel insights into all aspects of medicines and the future of health. If you would like your work to be considered, please send a presubmission enquiry to bmcmedicineeditorial@biomedcentral.com (please indicate which Journal you are enquiring about).

  1. There is increasing international policy and clinical interest in developing learning health systems and delivering precision medicine, which it is hoped will help reduce variation in the quality and safety of...

    Authors: Bright I. Nwaru, Charles Friedman, John Halamka and Aziz Sheikh
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2017 15:177
    Content type: Correspondence Published on:

  2. Globally, healthcare systems face major challenges with medicines management and medication adherence. Medication adherence determines medication effectiveness and can be the single most effective intervention...

    Authors: Josip Car, Woan Shin Tan, Zhilian Huang, Peter Sloot and Bryony Dean Franklin
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2017 15:73
    Content type: Opinion Published on:

  3. Asthma as a chronic health condition can be controlled when in addition to clinical care, adequate education and support is provided to enhance self-management. Like many other chronic health conditions improv...

    Authors: Philip O. Anum, Berko P. Anto and Audrey G. Forson
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:8
    Content type: Research Published on:

  4. The prevalence of non-communicable diseases (NCDs) is increasing in sub-Saharan Africa. At the same time, the use of mobile phones is rising, expanding the opportunities for the implementation of mobile phone-...

    Authors: Daniel Opoku, Victor Stephani and Wilm Quentin
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2017 15:24
    Content type: Research article Published on:

  5. Emerging and epidemic infectious disease outbreaks are a significant public health problem and global health security threat. As an outbreak begins, epidemiological investigations and traditional public health...

    Authors: Amanda M. Rojek and Peter W. Horby
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:212
    Content type: Opinion Published on:

  6. What does the future of medicine hold? We asked six researchers to share their most ambitious and optimistic views of the future, grounded in the present but looking out a decade or more from now to consider w...

    Authors: Paul Wicks, Matthew Hotopf, Vaibhav A. Narayan, Ethan Basch, James Weatherall and Muir Gray
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:176
    Content type: Forum Published on:

  7. The increasing threat of antimicrobial resistance combined with the paucity of new classes of antibiotics represents a serious public health challenge. New treatment technologies could, in theory, have a signi...

    Authors: Ejike Nwokoro, Ross Leach, Christine Ã…rdal, Enrico Baraldi, Kellie Ryan and Jens Plahte
    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:34
    Content type: Research Published on:

  8. The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between me...

    Authors: Dale Fisher, Paul Wicks and Zaheer-Ud-Din Babar
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:169
    Content type: Editorial Published on:

  9. The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between me...

    Authors: Dale Fisher, Paul Wicks and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:33
    Content type: Editorial Published on:

  10. The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-makers, who need to oversee the transformation of health systems that evolved to provide easy access to these drugs in...

    Authors: Gemma L. Buckland Merrett, Gerald Bloom, Annie Wilkinson and Hayley MacGregor
    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:31
    Content type: Review Published on:

  11. Corruption has been described as a disease. When corruption infiltrates global health, it can be particularly devastating, threatening hard gained improvements in human and economic development, international ...

    Authors: Tim K. Mackey, Jillian Clare Kohler, William D. Savedoff, Frank Vogl, Maureen Lewis, James Sale, Joshua Michaud and Taryn Vian
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:149
    Content type: Forum Published on:

  12. Shortages of medicines and vaccines have been reported in countries of all income levels in recent years. Shortages can result from one or multiple causes, including shortages of raw materials, manufacturing c...

    Authors: Swathi Iyengar, Lisa Hedman, Gilles Forte and Suzanne Hill
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:124
    Content type: Commentary Published on:

  13. Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments...

    Authors: Louise E. Curley, Janice Moody, Rukshar Gobarani, Trudi Aspden, Maree Jensen, Maureen McDonald, John Shaw and Janie Sheridan
    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:29
    Content type: Review Published on:

  14. Due to the easier access to information, the availability of low cost technologies and the involvement of well educated, passionate patients, a group of citizen ‘Health Hackers’, who are building their own med...

    Authors: Timothy Omer
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:118
    Content type: Commentary Published on:

  15. There is no more challenging a group of pharmaceuticals than antimicrobials. With the antibiotic era came great optimism as countless deaths were prevented from what were previously fatal conditions. Although ...

    Authors: Sze-Ann Woon and Dale Fisher
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:114
    Content type: Opinion Published on:

  16. Whilst it is clear that technology is crucial to advance healthcare: innovation in medicine is not just about high-tech tools, new procedures or genome discoveries. In constrained environments, healthcare prov...

    Authors: Viet-Thi Tran and Philippe Ravaud
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:102
    Content type: Commentary Published on:

  17. Priority setting is inevitable on the path towards universal health coverage. All countries experience a gap between their population’s health needs and what is economically feasible for governments to provide...

    Authors: Ole F. Norheim
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:75
    Content type: Commentary Published on:

  18. In life-threatening conditions such as cancer and rare diseases, where there is no cure and no U.S. Food and Drug Administration (FDA)-approved therapy, patients sometimes seek access to an unapproved, experim...

    Authors: Melissa Hogan
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:39
    Content type: Commentary Published on:

  19. In a research article published in ¾Á¸»ŠÊ˜·³Ç Medicine, Onakpoya and colleagues provide a historical review of withdrawals of medications for safety reasons. However, withdrawn medications are only one part of the pictu...

    Authors: Nigel S. B. Rawson
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:28
    Content type: Commentary Published on:

  20. There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of a...

    Authors: Igho J. Onakpoya, Carl J. Heneghan and Jeffrey K. Aronson
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:10
    Content type: Research article Published on:

    The has been published in ¾Á¸»ŠÊ˜·³Ç Medicine 2019 17:56

  21. Social media is fundamentally altering how we access health information and make decisions about medical treatment, including for terminally ill patients. This specifically includes the growing phenomenon of p...

    Authors: Tim K. Mackey and Virginia J. Schoenfeld
    Citation: ¾Á¸»ŠÊ˜·³Ç Medicine 2016 14:17
    Content type: Correspondence Published on: